ANA NLP Poster

October 17, 2016August 16, 2022 Alterity Therapeutics

ana-2016-poster-final

2016

Post navigation

XBRL 30 June 2023 filed with the SEC
Alterity Therapeutics Presents New Data on Multiple System Atrophy, a Rare Parkinsonian Disorder
Alterity Therapeutics Granted New Composition of Matter Patent in Europe for Neurodegenerative Diseases including Parkinson’s and Alzheimer’s
Alterity Therapeutics Rare Disease Natural History Study to be Featured at the International Congress of Parkinson’s Disease and Movement Disorders
Alterity Therapeutics Receives a $4.74 million Research & Development Tax Incentive Refund

We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases.
Improving lives.

Pipeline
The Science
About us
Investors
News

Careers
Privacy Policy

ANA NLP Poster

Related Posts

Prana Announces that PBT2 Reduces Cognitive Impairment Caused by Tau Protein Accumulation

Alterity Therapeutics to Present at the MST Access Australian Micro & Small Caps Conference

Alterity announces approval of US patent for next generation compounds to treat neurodegenerative diseases